XERAVA

Indicated For

Complicated intra-abdominal infections (cIAI)

About This Medication

# XERAVA Patient Assistance Guide: How to Get XERAVA at Low or No Cost XERAVA (eravacycline) is an injectable antibiotic used to treat complicated intra-abdominal infections (cIAI) in adults 18 years and older, but no specific patient assistance program is publicly detailed by the manufacturer, Innoviva Specialty Therapeutics, Inc.[1][3] This guide explains what is known about access options, general eligibility considerations for similar programs, and steps to pursue help based on available resources.[1][2][5] ## About XERAVA **XERAVA** is a broad-spectrum intravenous antibiotic indicated for **complicated intra-abdominal infections (cIAI)** caused by susceptible bacteria, including *Escherichia coli*, *Klebsiella pneumoniae*, *Enterococcus faecalis*, *Staphylococcus aureus*, and anaerobic species like *Bacteroides*.[1][3] It provides empiric coverage against Gram-positive, Gram-negative, and multidrug-resistant strains, proven effective as monotherapy compared to carbapenems like ertapenem or meropenem in phase 3 trials.[3] Administered by IV infusion every 12 hours (1 mg/kg actual body weight) for 4-14 days, guided by infection severity and clinical response, XERAVA requires no renal dose adjustments and is suitable for patients with mild to moderate hepatic impairment.[6] Common side effects include infusion site reactions (7.7%), nausea (6.5%), and vomiting (3.7%).[3] It's a **specialty medication** often used in hospitals for severe infections, potentially costly without coverage.[2][7] ## Who Qualifies for Assistance? No dedicated patient assistance program (PAP) with specific income thresholds, application methods, or eligibility criteria is listed on the official XERAVA site or manufacturer resources.[1][3] However, as a high-cost specialty drug from Innoviva Specialty Therapeutics (on behalf of Tetraphase Pharmaceuticals), patients may access support through: - **Manufacturer copay cards or savings programs** referenced for conditions like peritonitis.[5] - **Specialty pharmacy enrollment**, where your doctor's office or pharmacy may automatically enroll eligible patients.[2] - **Distributor ordering** for healthcare providers, which indirectly aids access.[1] General PAPs for similar antibiotics typically target **uninsured, underinsured, or low-income patients** (e.g., household income <400-500% of Federal Poverty Level), US residents aged 18+, with a valid prescription.[2] Medicare/Medicaid patients often have separate pathways, as XERAVA requires prior authorization under some plans.[4] ## Income Eligibility Breakdown Specific income thresholds for XERAVA are unavailable.[1] Below is a table of **typical thresholds** for comparable pharmaceutical PAPs (e.g., for specialty antibiotics), adjusted for a household of 1 in 2026 (scale up ~$5,000 per additional member): | Household Size | Annual Income Limit (Up to 400% FPL) | Annual Income Limit (Up to 500% FPL) | |---------------|-------------------------------------|-------------------------------------| | 1 | ~$60,000 | ~$75,000 | | 2 | ~$81,000 | ~$101,000 | | 3 | ~$102,000 | ~$128,000 | | 4 | ~$123,000 | ~$154,000 | *Note: FPL estimates for 2026; confirm current guidelines. Programs may exclude high assets or require proof of no other coverage.*[2] ## Insurance Requirements XERAVA coverage varies: - **Commercial/Exchange/CHIP/Medicaid**: Often requires prior authorization, proving age ≥18, failed/susceptibility issues with formulary antibiotics (e.g., not covered by cheaper options), up to 14 days.[4] - **Medicare**: Similar criteria; case-by-case for Medicaid non-qualifiers.[4] - **Uninsured/Underinsured**: Seek manufacturer programs; specialty pharmacies may bridge gaps.[2][5] If insured, PAPs typically cover copays/deductibles but not if government insurance (e.g., Medicare) is primary. Contact insurer first.[4] ## Step-by-Step Application Process 1. **Get a Prescription**: Ask your doctor for XERAVA if cIAI is confirmed via culture/sensitivity.[1][4] 2. **Check Insurance**: Verify coverage/prior auth with your plan.[4] 3. **Contact Manufacturer**: Call Innoviva Specialty Therapeutics at **1-800-651-3861** for adverse events/resources; inquire about PAP/copay assistance.[1][5] 4. **Use Copay Savings**: Visit sites like RxCopays.com for **XERAVA copay cards** from Innoviva.[5] 5. **Order via Distributors**: Providers contact Cardinal Health (1-866-677-4844), McKesson (1-877-625-2566), etc.[1] 6. **Specialty Pharmacy**: GoodRx notes automatic enrollment possible.[2] 7. **Submit Docs**: Typically prescription, income proof (tax returns, paystubs), ID, insurance denial (if applicable).[2] No online application URL or phone specified; start with manufacturer.[1] ## Timeline and Delivery - **Processing**: Unknown for PAP; insurance prior auth ~days to weeks.[4] - **Hospital Use**: Immediate via IV in facilities.[6] - **Delivery**: Distributors ship to providers; patient assistance likely to pharmacy/doctor.[1][2] Typical PAP approval: 1-4 weeks; refills may need reauth.[2] ## Alternatives if Denied - **Cheaper Antibiotics**: Ertapenem/meropenem if susceptible (XERAVA compared favorably).[3] - **GoodRx Coupons**: Save up to 80% at pharmacies.[2] - **Other PAPs**: PAN Foundation, HealthWell for antibiotics. - **Medicaid/Medicare Appeals**: Document intolerance to alternatives.[4] - **Generics**: Formulary options per culture.[4] ## Disclaimer This guide synthesizes public info as of 2026; no official XERAVA PAP details exist online.[1][3] Consult healthcare provider, manufacturer (1-800-651-3861), or financial counselor. Not medical/financial advice. Report side effects to FDA (1-800-FDA-1088).[1] Eligibility/coverage subject to change; verify directly. (Word count: 942)

Program information last verified: March 30, 2026